Skip to main content

Table 3 Clinical characteristics of patients with epithelial ovarian cancer recruited for ELISA

From: Ovarian cancer circulating extracelluar vesicles promote coagulation and have a potential in diagnosis: an iTRAQ based proteomic analysis

Number

CA125 (0.00–35.00 U/ml)

HE (40–81.9 pmol/L)

Prothrombin time (11–14.5 s)

DDI(0.00–0.5μg/ml)

CRP (0.0-5 mg/L)

Histopathology

FIGO stage

Postoperative residual tumor

1

190.4

244.3

12.2

0.96

NA

EEC

IIIB

0

2

1586

233.9

14.8

> 20.00

NA

HGSC

IIIC

< 1 cm

3

> 5000.00

855.6

13.1

9.59

NA

HGSC

IIIC

0

4

> 5000.00

> 1500

13.2

5.38

32.1

HGSC

IIIC

NA

5

752.1

465.1

12.3

0.75

NA

HGSC

IIIC

< 0.5 cm

6

2195

> 1500

13.9

6.97

NA

HGSC

IIIC

> 1 cm

7

49.74

72.88

12.7

0.31

NA

HGSC

IIIB

0

8

1614

324.5

13.6

4.33

NA

HGSC

IV

< 1 cm

9

289.3

468.3

13.6

13.57

NA

HGSC

IIIC

< 0.5 cm

10

188

247.3

13.4

7.47

NA

HGSC

IIIC

< 0.5 cm

11

1451

378

12.4

4.62

22

HGSC

IVa

< 0.5 cm

12

> 5000

905.9

12.6

> 20.00

NA

HGSC

IVB

0

13

2753.00

214.70

12.7

3.55

NA

HGSC

IIIC

> 2 cm

14

1148

716.1

13.8

3.99

NA

HGSC

IIIB

0

15

572.4

678.6

12.8

4.20

NA

HGSC

IIIC

0.3 cm

16

646.7

305.3

13.1

10.7

35.7

HGSC

IIIb

0

17

671.4

63.85

13.5

3.45

NA

adenoca

NA

NA

18

> 5000

705.2

13.4

5.93

NA

HGSC

IIIA1

0

19

> 5000

> 1500

13.4

7.51

NA

HGSC

IVA

> 1 cm

20

511.8

> 1500

12.8

11.64

NA

HGSC

IIIC

0

21

> 5000

448.1

12.4

7.31

< 0.3

HGSC

IIIC

0

22

1296

562.2

12.7

6.74

15.4

HGSC

IIIC

0

23

235

180

13.5

2.8

16.1

CCC

IV

> 2 cm

24

1191

324.5

12.6

6.93

NA

HGSC

IIIC

> 1 cm

25

1137

> 1500

14.2

17.51

NA

HGSC

IIIC

< 0.2 cm

26

600.5

1168

12.5

16.27

NA

HGSC

IIIC

0

27

> 5000

633.2

14.9

4.53

NA

HGSC

IVB

0

28

2276

369.6

13.1

3.29

NA

HGSC

IVB

0

29

553.9

291

12.8

3.67

NA

HGSC

IV

0

30

> 5000

543.1

14

7.87

NA

HGSC

IIIC

0

31

1700

> 1500

13.9

14.99

NA

HGSC

IIIC

0

32

8.28

179.6

13.4

0.66

5.6

HGSC

IIIB

0

33

317.7

172.3

13.6

1.33

NA

HGSC

IIIC

0

34

2324

345.1

13.6

4.49

NA

HGSC

IIIC

> 2 cm

35

2661

> 1500

13.9

4.37

NA

HGSC

IVA

0

36

511.1

1221

13

12.26

NA

HGSC

IIIC

0

37

2430

229.5

14.2

6.08

19.9

HGSC

IIIC

0

38

1517

153.8

13.7

0.78

< 0.3

HGSC

IIIC

< 0.3 cm

39

921.2

788.6

13

7.36

NA

HGSC

IIIC

0

40

140.2

281.8

12.7

2.24

NA

HGSC

IIIC

0.1–0.2 cm

41

425.2

115.9

14.6

2.98

NA

HGSC

IIIC

< 1 cm

42

276

1436

14.3

2.64

38.4

HGSC

IIIC

0

43

1556

276.6

13.3

2.51

NA

HGSC

IIIB

0

44

1423

1015

13.2

5.73

6.5

HGSC

IIIC

0.1–0.2 cm

45

554.3

1265

14

6.15

18.8

HGSC

IIIC

0

46

885.1

208.2

12.7

11.29

NA

HGSC

IIIB

0

47

734.7

783.3

13

3.42

2.5

HGSC

IIIC

< 0.5 cm

48

793.6

179.1

14.8

9.24

74.1

HGSC

IIIC

0

49

280.5

329.6

12.2

17.61

NA

HGSC

IIIC

0

50

1343

> 1500

15.3

12.78

25.9

HGSC

IIIC

0

51

> 5000

131.9

13.4

7.87

NA

HGSC

IIIC

0

52

896.5

259

13

5.41

19

HGSC

IIIC

0

53

121

1236

13.3

3.49

NA

HGSC

IIIC

< 0.5 cm

54

728.2

326.5

13.2

1.95

2

HGSC

IIIB

0

55

816.9

> 1500

12.5

29.13

0.6

HGSC

IIIC

0

56

> 5000

291.5

12.6

1.36

38.3

HGSC

IIIC

0

57

2915

> 1500

12.2

6.21

NA

HGSC

IV

0.2

58

453.2

621

13.1

18.82

5.3

adenoca

IIIC

0

59

2253

251.8

12.7

2.05

1.2

HGSC

IIIC

< 1 cm

60

166.2

423.5

15.5

> 40

78.2

HGSC

NA

NA

  1. EEC endometrial adenocarcinoma, CCC clear cell carcinoma, HGSC high gread serous carcinoma, adenoca adenocarcinoma